Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Accumulated Depreciation & Amortization: 2022-2025

Historic Accumulated Depreciation & Amortization for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $666,717.

  • bioAffinity Technologies' Accumulated Depreciation & Amortization rose 35.11% to $666,717 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 38.98%. This contributed to the annual value of $536,251 for FY2024, which is 43.72% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Accumulated Depreciation & Amortization of $666,717 as of Q3 2025, which was up 6.76% from $624,481 recorded in Q2 2025.
  • bioAffinity Technologies' Accumulated Depreciation & Amortization's 5-year high stood at $666,717 during Q3 2025, with a 5-year trough of $800 in Q3 2022.
  • Over the past 3 years, bioAffinity Technologies' median Accumulated Depreciation & Amortization value was $452,974 (recorded in 2024), while the average stood at $461,725.
  • Data for bioAffinity Technologies' Accumulated Depreciation & Amortization shows a peak YoY skyrocketed of 41,895.00% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows bioAffinity Technologies' Accumulated Depreciation & Amortization stood at $269,180 in 2022, then soared by 38.61% to $373,123 in 2023, then soared by 43.72% to $536,251 in 2024, then skyrocketed by 35.11% to $666,717 in 2025.
  • Its Accumulated Depreciation & Amortization was $666,717 in Q3 2025, compared to $624,481 in Q2 2025 and $580,012 in Q1 2025.